This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Feb;50(2):111-2.

doi: 10.1136/thx.50.2.111.

Lipoxin A4: a novel anti-inflammatory molecule?

T H Lee

PMID: 7701445
PMCID: PMC473888
DOI: 10.1136/thx.50.2.111

Review

Lipoxin A4: a novel anti-inflammatory molecule?

T H Lee. Thorax. 1995 Feb.

. 1995 Feb;50(2):111-2.

doi: 10.1136/thx.50.2.111.

Author

T H Lee

PMID: 7701445
PMCID: PMC473888
DOI: 10.1136/thx.50.2.111

No abstract available

PubMed Disclaimer

Similar articles

Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo.
Dahlén SE, Franzén L, Raud J, Serhan CN, Westlund P, Wikström E, Björck T, Matsuda H, Webber SE, Veale CA, et al. Dahlén SE, et al. Adv Exp Med Biol. 1988;229:107-30. doi: 10.1007/978-1-4757-0937-7_9. Adv Exp Med Biol. 1988. PMID: 3421155 No abstract available.
Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH, Devchand PR, Wada K, Serhan CN. Qiu FH, et al. FASEB J. 2001 Dec;15(14):2736-8. doi: 10.1096/fj.01-0576fje. Epub 2001 Oct 29. FASEB J. 2001. PMID: 11687510
Pharmacodynamics of lipoxin A4 in airway smooth muscle.
Dahlén SE, Veale CA, Webber SE, Marron BE, Nicolaou KC, Serhan CN. Dahlén SE, et al. Agents Actions. 1989 Jan;26(1-2):93-5. doi: 10.1007/BF02126570. Agents Actions. 1989. PMID: 2711954 No abstract available.
Lipoxin-stable analogs: potential therapeutic downregulators of intestinal inflammation.
Gewirtz AT, Madara JL. Gewirtz AT, et al. Ernst Schering Res Found Workshop. 2000;(31):187-99. doi: 10.1007/978-3-662-04047-8_9. Ernst Schering Res Found Workshop. 2000. PMID: 10943333 Review. No abstract available.
[Progress in the study of lipoxin and leukotriene].
Wu SH. Wu SH. Sheng Li Ke Xue Jin Zhan. 1996 Jan;27(1):79-81. Sheng Li Ke Xue Jin Zhan. 1996. PMID: 8731993 Review. Chinese. No abstract available.

See all similar articles

Cited by

Resolution of inflammation pathways in preeclampsia-a narrative review.
Perucci LO, Corrêa MD, Dusse LM, Gomes KB, Sousa LP. Perucci LO, et al. Immunol Res. 2017 Aug;65(4):774-789. doi: 10.1007/s12026-017-8921-3. Immunol Res. 2017. PMID: 28391374 Review.
Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways.
Tylek K, Trojan E, Leśkiewicz M, Regulska M, Bryniarska N, Curzytek K, Lacivita E, Leopoldo M, Basta-Kaim A. Tylek K, et al. Cells. 2021 Sep 9;10(9):2373. doi: 10.3390/cells10092373. Cells. 2021. PMID: 34572022 Free PMC article.
Lipoxin A4 Regulates Lipopolysaccharide-Induced BV2 Microglial Activation and Differentiation via the Notch Signaling Pathway.
Wu J, Ding DH, Li QQ, Wang XY, Sun YY, Li LJ. Wu J, et al. Front Cell Neurosci. 2019 Feb 4;13:19. doi: 10.3389/fncel.2019.00019. eCollection 2019. Front Cell Neurosci. 2019. PMID: 30778288 Free PMC article.

References

1. Lancet. 1989 Mar 18;1(8638):584-8 - PubMed
1. Br J Pharmacol. 1988 Oct;95(2):562-8 - PubMed
1. Am Rev Respir Dis. 1989 Jul;140(1):148-53 - PubMed
1. Clin Sci (Lond). 1989 Aug;77(2):195-203 - PubMed
1. Acta Physiol Scand. 1989 Dec;137(4):571-2 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources